Literature DB >> 18279965

Cytotoxicity of mesoporous silica nanomaterials.

Anthony J Di Pasqua1, Krishna K Sharma, Yan-Li Shi, Bonnie B Toms, Wayne Ouellette, James C Dabrowiak, Tewodros Asefa.   

Abstract

We here measure the toxicity of MCM-41, a mesoporous silica nanomaterial, two of its functionalized analogs, AP-T, which has grafted aminopropyl groups and MP-T, which has grafted mercaptopropyl groups, and spherical silica nanoparticles (SiO(2)), toward human neuroblastoma (SK-N-SH) cells. Since the particles studied are not soluble in aqueous media, the metric used to report the cytotoxicity of these materials is a new quantity, Q(50), which is the number of particles required to inhibit normal cell growth by 50%. Determining the number of particles per gram of material applied to the cells required both the calculated and experimentally determined surface areas of these nanomaterials. This study shows that Q(50) increases in the order, MCM-41<MP-T<AP-T approximately SiO(2), showing that on a per particle basis, MCM-41 is the most cytotoxic material studied. For the three mesoporous silica materials in this study, cytotoxicity appears related to the adsorptive surface area of the particle, although the nature of the functional group cannot be ruled out. Silica nanospheres have the lowest surface area of the particles studied but since they exhibit a Q(50) value similar to that of AP-T, shape may also be important in the cytotoxicity of these materials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279965     DOI: 10.1016/j.jinorgbio.2007.12.028

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  22 in total

Review 1.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

2.  Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.

Authors:  Ying Wang; Qinfu Zhao; Yanchen Hu; Lizhang Sun; Ling Bai; Tongying Jiang; Siling Wang
Journal:  Int J Nanomedicine       Date:  2013-10-22

Review 3.  Biocompatibility assessment of Si-based nano- and micro-particles.

Authors:  Hamsa Jaganathan; Biana Godin
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

4.  Functionalized nanoporous silica for the removal of heavy metals from biological systems: adsorption and application.

Authors:  Wassana Yantasee; Ryan D Rutledge; Wilaiwan Chouyyok; Vichaya Sukwarotwat; Galya Orr; Cynthia L Warner; Marvin G Warner; Glen E Fryxell; Robert J Wiacek; Charles Timchalk; R Shane Addleman
Journal:  ACS Appl Mater Interfaces       Date:  2010-10       Impact factor: 9.229

Review 5.  Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.

Authors:  Nupura S Bhise; Ron B Shmueli; Joel C Sunshine; Stephany Y Tzeng; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2011-02-22       Impact factor: 6.648

6.  Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.

Authors:  Rubel Chakravarty; Shreya Goel; Hao Hong; Feng Chen; Hector F Valdovinos; Reinier Hernandez; Todd E Barnhart; Weibo Cai
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

7.  Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications.

Authors:  Wenjuan Gao; James C K Lai; Solomon W Leung
Journal:  Front Physiol       Date:  2012-08-21       Impact factor: 4.566

Review 8.  The nanosilica hazard: another variable entity.

Authors:  Dorota Napierska; Leen C J Thomassen; Dominique Lison; Johan A Martens; Peter H Hoet
Journal:  Part Fibre Toxicol       Date:  2010-12-03       Impact factor: 9.400

9.  In vitro biocompatibility of calcined mesoporous silica particles and fetal blood cells.

Authors:  Mohammed T Al Samri; Ankush V Biradar; Ahmed R Alsuwaidi; Ghazala Balhaj; Suleiman Al-Hammadi; Safa Shehab; Suhail Al-Salam; Saeed Tariq; Thachillath Pramathan; Sheela Benedict; Tewodros Asefa; Abdul-Kader Souid
Journal:  Int J Nanomedicine       Date:  2012-08-03

10.  A hybrid assembly by encapsulation of human cells within mineralised beads for cell therapy.

Authors:  Philippe Dandoy; Christophe F Meunier; Grégory Leroux; Virginie Voisin; Laetitia Giordano; Nathalie Caron; Carine Michiels; Bao-Lian Su
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.